{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:28Z","timestamp":1793320768144,"version":"4.5.0"},"reference-count":314,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00e0\u00adfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["1191003"],"award-info":[{"award-number":["1191003"]}],"id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2020.571185","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:45:42Z","timestamp":1599144342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson\u2019s and Huntington\u2019s Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Paulina","family":"Troncoso-Escudero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"P\u00e9rez-Arancibia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra V.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Grunenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene L.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e28719","DOI":"10.1371\/journal.pone.0028719","article-title":"Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector","volume":"6","author":"Addis","year":"2011","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.stemcr.2018.03.007","article-title":"hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a huntington disease mouse model","volume":"10","author":"Adil","year":"2018","journal-title":"Stem Cell Reports"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-f","article-title":"Parkinson\u2019s disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington\u2019s disease: implications for the functional anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-x","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"25960","DOI":"10.1038\/srep25960","article-title":"Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS","volume":"6","author":"Allodi","year":"2016","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington\u2019s disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat. Cell Mol. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s13311-013-0211-8","article-title":"Epigenetic landscape of Parkinson\u2019s disease: emerging role in disease mechanisms and therapeutic modalities","volume":"10","author":"Ammal Kaidery","year":"2013","journal-title":"Neurotherapeutics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncpneuro0193","article-title":"Surgery insight: deep brain stimulation for movement disorders","volume":"2","author":"Anderson","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/s0306-4522(97)00079-1","article-title":"Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington\u2019s disease","volume":"81","author":"Araujo","year":"1997","journal-title":"Neuroscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0306-4522(97)00266-2","article-title":"Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid","volume":"82","author":"Araujo","year":"1998","journal-title":"Neuroscience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/0896-6273(95)90024-1","article-title":"GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo","volume":"15","author":"Arenas","year":"1995","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","article-title":"Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson\u2019s disease","volume":"22","author":"Azzouz","year":"2002","journal-title":"J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000101157","article-title":"Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates","volume":"48","author":"Bakay","year":"1985","journal-title":"Appl. Neurophysiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a new neurotrophic factor from mammalian brain","volume":"1","author":"Barde","year":"1982","journal-title":"EMBO J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-018-0087-1","article-title":"New approaches for brain repair-from rescue to reprogramming","volume":"557","author":"Barker","year":"2018","journal-title":"Nature"},{"key":"B19","first-page":"7","article-title":"[Therapeutic electric stimulation of deep brain structures]","volume":"36","author":"Bekhtereva","year":"1972","journal-title":"Vopr. Neirokhir."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1523\/JNEUROSCI.1615-07.2007","article-title":"Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia","volume":"27","author":"Berninger","year":"2007","journal-title":"J. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0006-8993(79)90472-4","article-title":"Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants","volume":"177","author":"Bj\u00f6rklund","year":"1979","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1046\/j.1471-4159.1997.69041629.x","article-title":"Energetic dysfunction in quinolinic acid-lesioned rat striatum","volume":"69","author":"Bordelon","year":"1997","journal-title":"J. Neurochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","article-title":"BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis","volume":"76","author":"Bramham","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tibs.2009.07.003","article-title":"Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure","volume":"34","author":"Brown","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jnen\/60.1.15","article-title":"High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats","volume":"60","author":"Bruet","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson\u2019s disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42234-020-00041-9","article-title":"Spinal cord stimulation in Parkinson\u2019s disease: a review of the preclinical and clinical data and future prospects","volume":"6","author":"Cai","year":"2020","journal-title":"Bioelectron. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0306-4522(93)90204-s","article-title":"Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents","volume":"53","author":"Campbell","year":"1993","journal-title":"Neuroscience"},{"key":"B35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnhum.2016.00611","article-title":"Striatal dopaminergic innervation regulates subthalamic beta-oscillations and cortical-subcortical coupling during movements: preliminary evidence in subjects with Parkinson\u2019s disease","volume":"10","author":"Canessa","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/mds.26146","article-title":"Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats","volume":"30","author":"Carcenac","year":"2015","journal-title":"Mov. Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1570159x17666181127125704","article-title":"Current drugs and potential future neuroprotective compounds for Parkinson\u2019s disease","volume":"17","author":"Carrera","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stemcr.2014.07.011","article-title":"Reversal of cellular phenotypes in neural cells derived from Huntington\u2019s disease monkey-induced pluripotent stem cells","volume":"3","author":"Carter","year":"2014","journal-title":"Stem Cell Reports"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3389\/fphar.2019.01494","article-title":"Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of Parkinson\u2019s disease","volume":"10","author":"Chambers","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fphar.2019.00444","article-title":"Current development of siRNA bioconjugates: from research to the clinic","volume":"10","author":"Chernikov","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","article-title":"Safety and tolerability of putaminal AADC gene therapy for Parkinson disease","volume":"73","author":"Christine","year":"2009","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/jcem-73-2-401","article-title":"Insulin-like growth factors (IGFs), IGF receptors and IGF-binding proteins in primary cultures of prostate epithelial cells","volume":"73","author":"Cohen","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","article-title":"Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington\u2019s disease: restoration by the neuroprotective compound CEP-1347","volume":"39","author":"Conforti","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"B2550","volume-title":"The Biochemical Basis of Neuropharmacology.","author":"Cooper","year":"2004"},{"key":"B46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of Parkinsonism\u2014chronic treatment with L-dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/nejm196702162760703","article-title":"Aromatic amino acids and modification of Parkinsonism","volume":"276","author":"Cotzias","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cne.901800208","article-title":"In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage","volume":"180","author":"Coyle","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(87)90322-8","article-title":"Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders","volume":"21","author":"Crossman","year":"1987","journal-title":"Neuroscience"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/brain\/111.5.1211","article-title":"Chorea and myoclonus in the monkey induced by \u03b3-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea","volume":"111","author":"Crossman","year":"1988","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnins.2018.00075","article-title":"Precise excision of the CAG tract from the huntingtin gene by Cas9 nickases","volume":"12","author":"Dabrowska","year":"2018","journal-title":"Front. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/bmj.2.5654.422","article-title":"Effect of tetrabenazine on extrapyramidal movement disorders","volume":"2","author":"Dalby","year":"1969","journal-title":"Br. Med. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"B55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/dddt.s138828","article-title":"Review of deutetrabenazine: a novel treatment for chorea associated with Huntington\u2019s disease","volume":"12","author":"Dean","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10143-015-0651-1","article-title":"Spinal cord stimulation for Parkinson\u2019s disease: a systematic review","volume":"39","author":"de Andrade","year":"2016","journal-title":"Neurosurg. Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(83)90150-4","article-title":"Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington\u2019s disease by day 18 fetal striatal implants","volume":"93","author":"Deckel","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"B57","first-page":"468","article-title":"Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients","volume":"18","author":"di Cianni","year":"1992","journal-title":"Diabete Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/brainsci8080138","article-title":"Spinal cord stimulation for neuropathic pain: current trends and future applications","volume":"8","author":"Dones","year":"2018","journal-title":"Brain Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S1353-8020(11)70018-9","article-title":"Neuronal vulnerability in Parkinson\u2019s disease","volume":"18","author":"Double","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/bf00242009","article-title":"Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats","volume":"104","author":"Duan","year":"1995","journal-title":"Exp. Brain Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cne.902670402","article-title":"Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum","volume":"267","author":"Dub\u00e9","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","article-title":"Results from a phase I safety trial of hAADC gene therapy for Parkinson disease","volume":"70","author":"Eberling","year":"2008","journal-title":"Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson\u2019s disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B66","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/mds.25625","article-title":"Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit","volume":"28","author":"Eskow Jaunarajs","year":"2013","journal-title":"Mov. Disord."},{"key":"B68","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease","volume":"17","author":"Evans","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington\u2019s disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"E1234","DOI":"10.1073\/pnas.1611473114","article-title":"Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1","volume":"114","author":"Faedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/WCO.0000000000000226","article-title":"Deep brain stimulation for movement disorders: 2015 and beyond","volume":"28","author":"Fasano","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.parkreldis.2011.07.015","article-title":"Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson\u2019s disease","volume":"18","author":"F\u00e9nelon","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuron.2018.09.015","article-title":"Connecting circuits for supraspinal control of locomotion","volume":"100","author":"Ferreira-Pinto","year":"2018","journal-title":"Neuron"},{"key":"B76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0006-8993(00)02237-x","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1523\/JNEUROSCI.2060-16.2017","article-title":"Subthalamic nucleus deep brain stimulation employs trkB signaling for neuroprotection and functional restoration","volume":"37","author":"Fischer","year":"2017","journal-title":"J. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroscience.2011.07.072","article-title":"Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor","volume":"194","author":"Fletcher","year":"2011","journal-title":"Neuroscience"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/nejm199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/archneur.1990.00530050021007","article-title":"Transplantation of human fetal dopamine cells for Parkinson\u2019s disease. Results at 1 year","volume":"47","author":"Freed","year":"1990","journal-title":"Arch. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington\u2019s disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","article-title":"Selective vulnerability in neurodegenerative diseases","volume":"21","author":"Fu","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1126\/science.1164901","article-title":"Spinal cord stimulation restores locomotion in animal models of Parkinson\u2019s disease","volume":"323","author":"Fuentes","year":"2009","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0306-4522(96)00152-2","article-title":"Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain","volume":"74","author":"Funa","year":"1996","journal-title":"Neuroscience"},{"key":"B86","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2008.06.003","article-title":"Development of human striatal anlagen after transplantation in a patient with Huntington\u2019s disease","volume":"213","author":"Gallina","year":"2008","journal-title":"Exp. Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnana.2015.00005","article-title":"Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state","volume":"9","author":"Galvan","year":"2015","journal-title":"Front. Neuroanat."},{"key":"B88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2008.12.010","article-title":"Effective GDNF brain delivery using microspheres\u2014a promising strategy for Parkinson\u2019s disease","volume":"135","author":"Garbayo","year":"2009","journal-title":"J. Control Release"},{"key":"B89","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3389\/fnins.2019.00669","article-title":"Huntington\u2019s disease patient-derived astrocytes display electrophysiological impairments and reduced neuronal support","volume":"13","author":"Garcia","year":"2019","journal-title":"Front. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02183-1","article-title":"Insulin-like growth factor 2 (IGF2) protects against Huntington\u2019s disease through the extracellular disposal of protein aggregates","author":"Garc\u00eda-Huerta","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e0149776","DOI":"10.1371\/journal.pone.0149776","article-title":"Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of Parkinson\u2019s disease","volume":"11","author":"Garea-Rodr\u00edguez","year":"2016","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF03346653","article-title":"Growth hormone\/insulin-like growth factor I axis in neurodegenerative diseases","volume":"33","author":"Gasperi","year":"2010","journal-title":"J. Endocrinol. Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-017-0307-1","article-title":"Gene suppression approaches to neurodegeneration","volume":"9","author":"Ghosh","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0896-6273(02)00682-7","article-title":"Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"B96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s007020170096","article-title":"Freezing of gait in patients with advanced Parkinson\u2019s disease","volume":"108","author":"Giladi","year":"2001","journal-title":"J. Neural Transm."},{"key":"B97","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"key":"B99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0378-4274(85)90123-7","article-title":"Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants","volume":"27","author":"Gould","year":"1985","journal-title":"Toxicol. Lett."},{"key":"B100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpharm.2007.05.027","article-title":"Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats","volume":"343","author":"Grandoso","year":"2007","journal-title":"Int. J. Pharm."},{"key":"B101","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-981-13-9913-8_14","article-title":"Astrocytes in Huntington\u2019s disease","volume":"1175","author":"Gray","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/jneurosci.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1523\/jneurosci.23-05-01974.2003","article-title":"Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys","volume":"23","author":"Grondin","year":"2003","journal-title":"J. Neurosci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","author":"Grondin","year":"2012","journal-title":"Brain"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awf234","article-title":"Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys","volume":"125","author":"Grondin","year":"2002","journal-title":"Brain"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00702-014-1201-7","article-title":"Quadruple deep brain stimulation in Huntington\u2019s disease, targeting pallidum and subthalamic nucleus: case report and review of the literature","volume":"121","author":"Gruber","year":"2014","journal-title":"J. Neural Transm."},{"key":"B107","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/s0006-8993(00)01988-0","article-title":"N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats","volume":"859","author":"Guan","year":"2000","journal-title":"Brain Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s007020170099","article-title":"Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat","volume":"108","author":"Haasio","year":"2001","journal-title":"J. Neural Transm."},{"key":"B109","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1755-5949.2008.00058.x","article-title":"Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson\u2019s disease","volume":"14","author":"Hadjiconstantinou","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/brain\/122.6.1121","article-title":"Sequential bilateral transplantation in Parkinson\u2019s disease: effects of the second graft","volume":"122","author":"Hagell","year":"1999","journal-title":"Brain"},{"key":"B111","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1073\/pnas.89.9.4187","article-title":"Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease","volume":"89","author":"Hantraye","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B113","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/2010.4.focus10106","article-title":"Deep brain stimulation between 1947 and 1987: the untold story","volume":"29","author":"Hariz","year":"2010","journal-title":"Neurosurg. Focus"},{"key":"B114","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.expneurol.2007.10.002","article-title":"Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism","volume":"210","author":"Harnack","year":"2008","journal-title":"Exp. Neurol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jocn.2012.08.018","article-title":"A patient with Parkinson\u2019s disease benefits from spinal cord stimulation","volume":"20","author":"Hassan","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbrc.2006.01.057","article-title":"Down-regulation of \u03b1-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson\u2019s disease rat model","volume":"341","author":"Hayashita-Kinoh","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B118","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbr.2014.01.014","article-title":"High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat","volume":"263","author":"He","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci. Lett."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e1000373","DOI":"10.1371\/journal.pbio.1000373","article-title":"Directing astroglia from the cerebral cortex into subtype specific functional neurons","volume":"8","author":"Heinrich","year":"2010","journal-title":"PLoS Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol. Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1531-8257(199903)14:2<383::aid-mds1037>3.0.co;2-f","article-title":"Dopaminergic neurons degenerate by apoptosis in Parkinson\u2019s disease","volume":"14","author":"Hirsch","year":"1999","journal-title":"Mov. Disord."},{"key":"B123","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s41048-018-0066-y","article-title":"PTB\/nPTB: master regulators of neuronal fate in mammals","volume":"4","author":"Hu","year":"2018","journal-title":"Biophys. Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0306-4522(85)90095-8","article-title":"Neural grafting in a rat model of Huntington\u2019s disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting","volume":"16","author":"Isacson","year":"1985","journal-title":"Neuroscience"},{"key":"B129","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/311458a0","article-title":"Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum","volume":"311","author":"Isacson","year":"1984","journal-title":"Nature"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e9575","DOI":"10.15252\/emmm.201809575","article-title":"Cellular, molecular and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments","volume":"11","author":"Jakobs","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2ra4","DOI":"10.1126\/scitranslmed.3000130","article-title":"Dopamine gene therapy for Parkinson\u2019s disease in a nonhuman primate without associated dyskinesia","volume":"1","author":"Jarraya","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2007.06.058","article-title":"Beta-amyloid toxicity and reversal in embryonic rat septal neurons","volume":"423","author":"Jarvis","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B133","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset","volume":"50","author":"Jenner","year":"1984","journal-title":"Neurosci. Lett."},{"key":"B134","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0959-4388(00)00092-1","article-title":"Neurotrophin signal transduction in the nervous system","volume":"10","author":"Kaplan","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington\u2019s disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1517\/14740338.2015.1015986","article-title":"Safety of IPX066, an extended release carbidopa-levodopa formulation, for the treatment of Parkinson\u2019s disease","volume":"14","author":"Kestenbaum","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"B137","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-0037-1601567","article-title":"Genetic forms of Parkinson\u2019s disease","volume":"37","author":"Kim","year":"2017","journal-title":"Semin. Neurol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.stem.2011.09.011","article-title":"Functional integration of dopaminergic neurons directly converted from mouse fibroblasts","volume":"9","author":"Kim","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1016\/s1525-0016(16)43116-3","article-title":"Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer","volume":"99","author":"Kirik","year":"","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/jneurosci.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of \u03b1-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"","journal-title":"J. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"Kitada","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B142","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P \u03b1-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.07.002","article-title":"New mode of burst spinal cord stimulation improved mental status as well as motor function in a patient with Parkinson\u2019s disease","volume":"57","author":"Kobayashi","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B144","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington\u2019s disease patients","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp. Neurol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mds.870130303","article-title":"Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson\u2019s disease","volume":"13","author":"Kordower","year":"1998","journal-title":"Mov. Disord."},{"key":"B148","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/01.wnr.0000127461.15985.07","article-title":"N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats","volume":"15","author":"Krishnamurthi","year":"2004","journal-title":"Neuroreport"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1460-9568.2006.04717.x","article-title":"Reduction in subthalamic 8\u201335 Hz oscillatory activity correlates with clinical improvement in Parkinson\u2019s disease","volume":"23","author":"Kuhn","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1460-9568.2003.02408.x","article-title":"The mouse MPTP model: gene expression changes in dopaminergic neurons","volume":"17","author":"K\u00fchn","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnagi.2020.00164","article-title":"Long-term continuous cervical spinal cord stimulation exerts neuroprotective effects in experimental Parkinson\u2019s disease","volume":"12","author":"Kuwahara","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fnagi.2017.00365","article-title":"Insulin-like growth factor-1 and neuroinflammation","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-b","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"key":"B157","doi-asserted-by":"publisher","first-page":"20527","DOI":"10.1074\/jbc.m115.662254","article-title":"The solution structure and dynamics of full-length human cerebral dopamine neurotrophic factor and its neuroprotective role against \u03b1-synuclein oligomers","volume":"290","author":"Latge","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1178626419842176","DOI":"10.1177\/1178626419842176","article-title":"The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system","volume":"12","author":"Lewitt","year":"2019","journal-title":"Biochem. Insights"},{"key":"B159","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.neuron.2016.08.004","article-title":"In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells","volume":"91","author":"Li","year":"2016","journal-title":"Neuron"},{"key":"B160","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"B164","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant \u03b1-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"B162","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B165","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature05957","article-title":"Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo","volume":"448","author":"Lindholm","year":"2007","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson\u2019s disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.410310206","article-title":"Transplantation of fetal dopamine neurons in Parkinson\u2019s disease: one-year clinical and neurophysiological observations in two patients with putaminal implants","volume":"31","author":"Lindvall","year":"1992","journal-title":"Ann. Neurol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington\u2019s disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"e60447","DOI":"10.1371\/journal.pone.0060447","article-title":"Striatal molecular signature of subchronic subthalamic nucleus high frequency stimulation in parkinsonian rat","volume":"8","author":"Lortet","year":"2013","journal-title":"PLoS One"},{"key":"B171","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"BDNF and synaptic plasticity, cognitive function and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of \u03b1-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B173","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/cr.2009.56","article-title":"Adult neural stem cells in the mammalian central nervous system","volume":"19","author":"Ma","year":"2009","journal-title":"Cell Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3171\/jns.2004.100.4.0679","article-title":"Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons","volume":"100","author":"Maesawa","year":"2004","journal-title":"J. Neurosurg."},{"key":"B175","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B176","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00702-012-0876-x","article-title":"\u201c70th Birthday Professor Riederer\u201d induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (\u2212)deprenyl: a way to a disease-modifying therapy?","volume":"120","author":"Maruyama","year":"2013","journal-title":"J. Neural Transm."},{"key":"B177","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/brainsci9040078","article-title":"High cervical spinal cord stimulation: a one year follow-up study on motor and non-motor functions in Parkinson\u2019s disease","volume":"9","author":"Mazzone","year":"2019","journal-title":"Brain Sci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"B179","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1111\/j.1460-9568.2006.05198.x","article-title":"Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains","volume":"24","author":"McLin","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1471-4159.2003.01665.x","article-title":"High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats","volume":"85","author":"Meissner","year":"2003","journal-title":"J. Neurochem."},{"key":"B181","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fncel.2018.00401","article-title":"Astrocyte heterogeneity in the adult central nervous system","volume":"12","author":"Miller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B183","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther."},{"key":"B184","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/2013.jamaneurol.45","article-title":"History, applications, and mechanisms of deep brain stimulation","volume":"70","author":"Miocinovic","year":"2013","journal-title":"JAMA Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/hum.2011.220","article-title":"Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson\u2019s disease","volume":"23","author":"Mittermeyer","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"B186","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B187","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant huntingtin allele in vitro and in vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"B188","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Reports"},{"key":"B189","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ana.20183","article-title":"Bilateral globus pallidus stimulation for Huntington\u2019s disease","volume":"56","author":"Moro","year":"2004","journal-title":"Ann. Neurol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1590\/0004-282X20150029","article-title":"Non-motor signs in Parkinson\u2019s disease: a review","volume":"73","author":"Munhoz","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"B191","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/10430340252792486","article-title":"Behavioral recovery in a primate model of Parkinson\u2019s disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes","volume":"13","author":"Muramatsu","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/mt.2010.135","article-title":"A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson\u2019s disease","volume":"18","author":"Muramatsu","year":"2010","journal-title":"Mol. Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ana.24947","article-title":"Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T \u03b1-synuclein Parkinson\u2019s disease rat model","volume":"81","author":"Musacchio","year":"2017","journal-title":"Ann. Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/bf00228749","article-title":"Platelet-derived growth factor exerts trophic effects on rat striatal DARPP-32-containing neurons in culture","volume":"101","author":"Nakao","year":"1994","journal-title":"Exp. Brain Res."},{"key":"B195","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0306-4522(98)00197-3","article-title":"Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington\u2019s disease","volume":"88","author":"Nakao","year":"1999","journal-title":"Neuroscience"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington\u2019s disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"B197","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/ner.12315","article-title":"Beneficial therapeutic effects of spinal cord stimulation in advanced cases of Parkinson\u2019s disease with intractable chronic pain: a case series","volume":"18","author":"Nishioka","year":"2015","journal-title":"Neuromodulation"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.stemcr.2018.09.004","article-title":"Phenotypic reprogramming of striatal neurons into dopaminergic neuron-like cells in the adult mouse brain","volume":"11","author":"Niu","year":"2018","journal-title":"Stem Cell Reports"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ncb2843","article-title":"In vivo reprogramming of astrocytes to neuroblasts in the adult brain","volume":"15","author":"Niu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/wnl.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"B201","doi-asserted-by":"publisher","first-page":"S548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: therapeutic implications for Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov. Disord."},{"key":"B202","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/s1474-4422(06)70521-x","article-title":"Continuous dopamine-receptor treatment of Parkinson\u2019s disease: scientific rationale and clinical implications","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-8-44","article-title":"rAAV2\/7 vector-mediated overexpression of \u03b1-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"Oliveras-Salv\u00e1","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","article-title":"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial","volume":"383","author":"Palfi","year":"2014","journal-title":"Lancet"},{"key":"B207","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","article-title":"Reduced expression of brain-derived neurotrophic factor protein in Parkinson\u2019s disease substantia nigra","volume":"10","author":"Parain","year":"1999","journal-title":"Neuroreport"},{"key":"B208","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"B209","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.410420511","article-title":"Entacapone improves motor fluctuations in levodopa-treated Parkinson\u2019s disease patients. Parkinson Study Group","volume":"42","year":"1997","journal-title":"Ann. Neurol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archneur.62.2.241","article-title":"A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study","volume":"62","year":"2005","journal-title":"Arch. Neurol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.15252\/emmm.201404228","article-title":"Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice","volume":"6","author":"Pascual-Lucas","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B212","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.20374","article-title":"Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study","volume":"57","author":"Patel","year":"2005","journal-title":"Ann. Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI79635","article-title":"Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson\u2019s disease patients","volume":"125","author":"Paul","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B214","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2202-6-71","article-title":"Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity","volume":"6","author":"Perez","year":"2005","journal-title":"BMC Neurosci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.571147","article-title":"Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system","volume":"204","author":"Perlow","year":"1979","journal-title":"Science"},{"key":"B216","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1083\/jcb.200203115","article-title":"TGF\u03b2 induces GDNF responsiveness in neurons by recruitment of GFR\u03b11 to the plasma membrane","volume":"159","author":"Peterziel","year":"2002","journal-title":"J. Cell Biol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/jmn:20:2:173","article-title":"MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons","volume":"20","author":"Petrova","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1073\/pnas.1105135108","article-title":"Direct conversion of human fibroblasts to dopaminergic neurons","volume":"108","author":"Pfisterer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B220","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jnr.490310203","article-title":"Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen nuclei","volume":"31","author":"Pickel","year":"1992","journal-title":"J. Neurosci. Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0304-3940(96)12326-0","article-title":"Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture","volume":"204","author":"Pietz","year":"1996","journal-title":"Neurosci. Lett."},{"key":"B222","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mds.26850","article-title":"Spinal cord stimulation improves gait in patients with Parkinson\u2019s disease previously treated with deep brain stimulation","volume":"32","author":"Pinto de Souza","year":"2017","journal-title":"Mov. Disord."},{"key":"B223","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1034\/j.1600-0404.2002.1o174.x","article-title":"Efficacy and safety of entacapone in Parkinson\u2019s disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)","volume":"105","author":"Poewe","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","article-title":"Role of metabolism in neurodegenerative disorders","volume":"65","author":"Procaccini","year":"2016","journal-title":"Metabolism"},{"key":"B226","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","article-title":"Reversing a model of Parkinson\u2019s disease with in situ converted nigral neurons","volume":"582","author":"Qian","year":"2020","journal-title":"Nature"},{"key":"B227","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.clinph.2017.03.043","article-title":"Cortical plasticity and levodopa-induced dyskinesias in Parkinson\u2019s disease: connecting the dots in a multicomponent network","volume":"128","author":"Rajan","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/s0140-6736(05)71083-7","article-title":"Rasagiline as an adjunct to levodopa in patients with Parkinson\u2019s disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial","volume":"365","author":"Rascol","year":"2005","journal-title":"Lancet"},{"key":"B229","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-1106","DOI":"10.12688\/f1000research.14528.1","article-title":"An early diagnosis is not the same as a timely diagnosis of Parkinson\u2019s disease","volume":"7","author":"Rees","year":"2018","journal-title":"F1000Res."},{"key":"B230","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.disamonth.2007.05.002","article-title":"Current pharmacotherapeutic treatment options in Parkinson\u2019s disease","volume":"53","author":"Rezak","year":"2007","journal-title":"Dis. Mon."},{"key":"B231","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1212\/wnl.51.5.1309","article-title":"Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Nomecomt Study Group","volume":"51","author":"Rinne","year":"1998","journal-title":"Neurology"},{"key":"B233","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model","volume":"35","author":"Rivetti di Val Cervo","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-8993(89)91252-3","article-title":"Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus","volume":"476","author":"Robertson","year":"1989","journal-title":"Brain Res."},{"key":"B235","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"B236","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","article-title":"High insulinlike growth factor I is associated with cognitive decline in Huntington disease","volume":"75","author":"Saleh","year":"2010","journal-title":"Neurology"},{"key":"B238","doi-asserted-by":"publisher","first-page":"e0162890","DOI":"10.1371\/journal.pone.0162890","article-title":"Insulin-like growth factor-1 but not insulin predicts cognitive decline in Huntington\u2019s disease","volume":"11","author":"Salem","year":"2016","journal-title":"PLoS One"},{"key":"B239","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mds.27299","article-title":"Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson\u2019s disease patients","volume":"33","author":"Samotus","year":"2018","journal-title":"Mov. Disord."},{"key":"B240","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","volume":"284","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"B241","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0091-3057(86)90269-8","article-title":"Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington\u2019s disease","volume":"25","author":"Sanberg","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B242","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.neuron.2014.08.061","article-title":"Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease","volume":"84","author":"Santana","year":"2014","journal-title":"Neuron"},{"key":"B243","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B244","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1213\/00000539-196707000-00025","article-title":"Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report","volume":"46","author":"Shealy","year":"1967","journal-title":"Anesth. Analg."},{"key":"B245","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1093\/hmg\/ddw286","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B246","doi-asserted-by":"publisher","first-page":"e101468","DOI":"10.1371\/journal.pone.0101468","article-title":"Spinal cord stimulation exerts neuroprotective effects against experimental Parkinson\u2019s disease","volume":"9","author":"Shinko","year":"2014","journal-title":"PLoS One"},{"key":"B247","doi-asserted-by":"publisher","first-page":"309431","DOI":"10.1155\/2012\/309431","article-title":"Movement disorders and neuromodulation","volume":"2012","author":"Shipton","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"B248","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0165-0173(00)00030-8","article-title":"Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s disease brain","volume":"33","author":"Siegel","year":"2000","journal-title":"Brain Res. Rev."},{"key":"B249","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s002210050338","article-title":"Expression of platelet-derived growth factor after intrastriatal ibotenic acid injury","volume":"119","author":"Sj\u00f6borg","year":"1998","journal-title":"Exp. Brain Res."},{"key":"B250","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1749-6632.1987.tb23706.x","article-title":"Reversal of parkinsonism by fetal nerve cell transplants in primate brain","volume":"495","author":"Sladek","year":"1987","journal-title":"Ann. N Y Acad. Sci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3171\/jns.2007.106.4.614","article-title":"Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal","volume":"106","author":"Slevin","year":"2007","journal-title":"J. Neurosurg."},{"key":"B252","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B254","first-page":"251","article-title":"Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia","volume":"2","author":"Smith","year":"1987","journal-title":"Histol. Histopathol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s12035-014-8958-4","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease: risk, mechanisms and therapy","volume":"52","author":"Song","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0278-5846(88)90054-1","article-title":"Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice","volume":"12","author":"Sonsalla","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B257","first-page":"850","article-title":"Characteristics of 1-methyl-4\u2013(2\u2032-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse","volume":"242","author":"Sonsalla","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B258","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nbd.2010.03.009","article-title":"Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss","volume":"39","author":"Spieles-Engemann","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B259","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/jpd-2011-11008","article-title":"Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex","volume":"1","author":"Spieles-Engemann","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","article-title":"Dopamine turnover and glutathione oxidation: implications for Parkinson disease","volume":"86","author":"Spina","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B261","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.cell.2016.08.055","article-title":"In vivo cellular reprogramming: the next generation","volume":"166","author":"Srivastava","year":"2016","journal-title":"Cell"},{"key":"B263","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ncl.2009.04.009","article-title":"Medical treatment of Parkinson disease","volume":"27","author":"Stacy","year":"2009","journal-title":"Neurol. Clin."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of \u03b1-synuclein in mouse substantia nigra","volume":"100","author":"St. Martin","year":"2007","journal-title":"J. Neurochem."},{"key":"B264","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ana.25475","article-title":"Deep brain stimulation: connectivity profile for bradykinesia alleviation","volume":"85","author":"Strotzer","year":"2019","journal-title":"Ann. Neurol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene therapy for neurodegenerative diseases","volume":"16","author":"Sudhakar","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B266","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-10-37","article-title":"Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators","volume":"10","author":"Suh","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B267","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B268","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B270","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1440-1789.2012.01302.x","article-title":"Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum","volume":"32","author":"Takahashi","year":"2012","journal-title":"Neuropathology"},{"key":"B269","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B271","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-7091-7494-4_5","article-title":"(\u2212)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase","volume":"48","author":"Tatton","year":"1996","journal-title":"J. Neural Transm. Suppl."},{"key":"B272","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/bf00229411","article-title":"Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls","volume":"85","author":"Taylor","year":"1991","journal-title":"Exp. Brain Res."},{"key":"B273","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.3390\/ijms19103199","article-title":"Pharmacoepigenomic interventions as novel potential treatments for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"19","author":"Teijido","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.brainres.2006.08.082","article-title":"Protection of nigral cell death by bilateral subthalamic nucleus stimulation","volume":"1120","author":"Temel","year":"2006","journal-title":"Brain Res."},{"key":"B275","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2014.01.009","article-title":"Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson\u2019s disease","volume":"65","author":"Tereshchenko","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1212\/WNL.0b013e3181d9ed58","article-title":"Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease","volume":"74","author":"Thevathasan","year":"2010","journal-title":"Neurology"},{"key":"B277","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.06.040","article-title":"In vivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry","volume":"12","author":"Torper","year":"2015","journal-title":"Cell Rep."},{"key":"B278","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1517\/17460441.2015.1041495","article-title":"Rational durg discovery design approaches for treating Parkinson\u2019s disease","volume":"10","author":"Van de Schyf","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B280","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/jneurosci.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"B281","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.expneurol.2010.12.013","article-title":"Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson\u2019s disease","volume":"228","author":"Voutilainen","year":"2011","journal-title":"Exp. Neurol."},{"key":"B282","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson\u2019s disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J. Neurosci."},{"key":"B283","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/brain\/awm137","article-title":"Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys","volume":"130","author":"Wallace","year":"2007","journal-title":"Brain"},{"key":"B284","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"B285","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","article-title":"Low BDNF is associated with cognitive impairments in patients with Parkinson\u2019s disease","volume":"29","author":"Wang","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B286","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1196\/annals.1403.011","article-title":"Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy","volume":"1122","author":"Weinreb","year":"2007","journal-title":"Ann. N Y Acad. Sci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"B288","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JPD-191576","article-title":"Extended treatment with glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"9","author":"Whone","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"B289","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awz023","article-title":"Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"142","author":"Whone","year":"2019","journal-title":"Brain"},{"key":"B290","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40472-019-00237-2","article-title":"Evasion of pre-existing immunity to Cas9: a prerequisite for successful genome editing in vivo?","volume":"6","author":"Wignakumar","year":"2019","journal-title":"Curr. Transplant. Rep."},{"key":"B291","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fneur.2015.00177","article-title":"A prospective pilot trial for pallidal deep brain stimulation in Huntington\u2019s disease","volume":"6","author":"Wojtecki","year":"2015","journal-title":"Front. Neurol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.3760\/cma.j.issn0366-6999.2012.22.029","article-title":"Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson\u2019s disease","volume":"125","author":"Wu","year":"2012","journal-title":"Chin. Med. J."},{"key":"B293","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"B294","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11910-017-0739-9","article-title":"Huntington\u2019s disease-update on treatments","volume":"17","author":"Wyant","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B295","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Reports"},{"key":"B296","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cell.2012.11.045","article-title":"Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits","volume":"152","author":"Xue","year":"2013","journal-title":"Cell"},{"key":"B297","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3410\/f.726310460.793517647","article-title":"Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells","volume":"19","author":"Xue","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B298","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1038\/srep03839","article-title":"Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions","volume":"4","author":"Yadav","year":"2014","journal-title":"Sci. Rep."},{"key":"B299","doi-asserted-by":"publisher","first-page":"S275","DOI":"10.4103\/2152-7806.103019","article-title":"Dorsal column stimulator applications","volume":"3","author":"Yampolsky","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"B302","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/jci92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B301","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington\u2019s disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"B300","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","article-title":"Expression of Huntington\u2019s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs","volume":"19","author":"Yang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B303","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","article-title":"Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"19","author":"Yasuhara","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B304","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JPD-2011-0003","article-title":"Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson\u2019s disease","volume":"1","author":"Zachrisson","year":"2011","journal-title":"J. Parkinsons Dis"},{"key":"B305","doi-asserted-by":"publisher","first-page":"RRN1193","DOI":"10.1371\/currents.RRN1193","article-title":"Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells","volume":"2","author":"Zhang","year":"2010","journal-title":"PLoS Curr."},{"key":"B306","first-page":"1396","article-title":"Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys","volume":"282","author":"Zhang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B308","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.03.029","article-title":"Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: recent developments","volume":"1665","author":"Zhao","year":"2017","journal-title":"Brain Res."},{"key":"B307","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","article-title":"Mechanisms and functional implications of adult neurogenesis","volume":"132","author":"Zhao","year":"2008","journal-title":"Cell"},{"key":"B309","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0024-3205(84)90147-4","article-title":"Parkinson\u2019s disease: studies with an animal model","volume":"35","author":"Zigmond","year":"1984","journal-title":"Life Sci."},{"key":"B310","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"B311","doi-asserted-by":"publisher","first-page":"e22966","DOI":"10.14711\/thesis-991012662566803412","article-title":"Brain-derived neurotrophic factor in patients with Huntington\u2019s disease","volume":"6","author":"Zuccato","year":"2011","journal-title":"PLoS One"},{"key":"B312","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0165-0173(01)00098-4","article-title":"Sustained delivery of GDNF: towards a treatment for Parkinson\u2019s disease","volume":"36","author":"Zurn","year":"2001","journal-title":"Brain Res. Rev."},{"key":"B313","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/archneur.1992.00530260052019","article-title":"Locus coeruleus involvement in Huntington\u2019s disease","volume":"49","author":"Zweig","year":"1992","journal-title":"Arch. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.571185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:45:48Z","timestamp":1599144348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.571185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":314,"alternative-id":["10.3389\/fnagi.2020.571185"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.571185","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"article-number":"571185"}}